MedPath

The evaluation of efficacy of topical use of Nigella cream (Nigella sativa oil-extract) in chonic hand eczema

Phase 3
Conditions
hand eczema.
Dermatitis, unspecified Eczema NOS
Registration Number
IRCT201111266959N3
Lead Sponsor
Skin research center of Shahid Beheshti university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria:
- age between 18-60 y/o
- patients should be eager to participate in trial
-patients should have chronic hand eczema that is confirmed by two dermatologist
separetely
Exclusion criteria:
-pregnancy and lactation
-application of topical drugs during previous two weeks
-usage of systemic therapies such as corticosteroids and immunosupressive drugs and antibiotics during the past 4 weeks
- localized hand infection
-history of hand contact dermatitis due to topical drugs including herbal remedies

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life. Timepoint: 2 weeks. Method of measurement: Dermatology Life Quality Index (DLQI).;Resolution of severity and intensity of lesions. Timepoint: 2 weeks. Method of measurement: Hand Eczema Severity Index (HECSI).
Secondary Outcome Measures
NameTimeMethod
Irritant or allergic contact dermatitis. Timepoint: 4 weeks. Method of measurement: physician assessment.
© Copyright 2025. All Rights Reserved by MedPath